Refractory acute disseminated encephalomyelitis with anti-galactocerebroside antibody

Neuroscience Research

Volumn 74, Issue 3-4, 2012, Pages 284-289

  Samukawa, Makoto ^a   Hirano, Makito ^a   Tsugawa, Jun ^b   Sakamoto, Hikaru ^a   Tabata, Emi ^c   Takada, Kazuo ^a   Kuwahara, Motoi ^a   Suzuki, Seiko ^a   Kitada, Mari ^a   Yamada, Tatsuo ^b   Hara, Hideo ^c   Tsuboi, Yoshio ^b   Nakamura, Yusaku ^a   Kusunoki, Susumu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

Acute disseminated encephalomyelitis; Anti galactocerebroside antibody; IVIg; Prognostic marker; Steroid resistance

Indexed keywords

ANTIBODY; GALACTOCEREBROSIDE ANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; STEROID THERAPY;

ADRENAL CORTEX HORMONES; ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; DRUG RESISTANCE; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; GALACTOSYLCERAMIDES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84871932615     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2012.09.006     Document Type: Article

References (18)

1. Dalakas M.C. Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 2004, 291:2367-2375.
2. Double-blind trial of intravenous methylprednisolone in Guillain-Barre syndrome. Lancet 1993, 341:586-590. Guillain-Barre Syndrome Steroid Trial Group.
3. Hattori N., Yamamoto M., Yoshihara T., Koike H., Nakagawa M., Yoshikawa H., Ohnishi A., Hayasaka K., Onodera O., Baba M., Yasuda H., Saito T., Nakashima K., Kira J., Kaji R., Oka N., Sobue G. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain 2003, 126:134-151.
4. Hiraga A., Mori M., Ogawara K., Kojima S., Kanesaka T., Misawa S., Hattori T., Kuwabara S. Recovery patterns and long term prognosis for axonal Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiatry 2005, 76:719-722.
5. Inoue Y., Yonezawa M., Yoshino H. Acute disseminated encephalomyelitis with anti-galatocerebroside antibody following Mycoplasma pneumoniae infection. Neurol. Med. 1997, 47:164-170. (in Japanese, with an English abstract).
6. Kumada S., Kusaka H., Okaniwa M., Kobayashi O., Kusunoki S. Encephalomyelitis subsequent to mycoplasma infection with elevated serum anti-Gal C antibody. Pediatr. Neurol. 1997, 16:241-244.
7. Kusunoki S., Shiina M., Kanazawa I. Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry. Neurology 2001, 57:736-738.
8. Limburg P.C., The T.H., Hummel-Tappel E., Oosterhuis H.J. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients. J. Neurol. Sci. 1983, 58:357-370.
9. Madrid R.E., Wisniewski H.M. Axonal degeneration in demyelinating disorders. J. Neurocytol. 1977, 6:103-117.
10. Marchioni E., Ravaglia S., Piccolo G., Furione M., Zardini E., Franciotta D., Alfonsi E., Minoli L., Romani A., Todeschini A., Uggetti C., Tavazzi E., Ceroni M. Postinfectious inflammatory disorders: subgroups based on prospective follow-up. Neurology 2005, 65:1057-1065.
11. Nishimura M., Saida T., Kuroki S., Kawabata T., Obayashi H., Saida K., Uchiyama T. Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection. J. Neurol. Sci. 1996, 140:91-95.
12. Oosterhuis H.J., Limburg P.C., Hummel-Tappel E., The T.H. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients. J. Neurol. Sci. 1983, 58:371-385.
13. Ravaglia S., Piccolo G., Ceroni M., Franciotta D., Pichiecchio A., Bastianello S., Tavazzi E., Minoli L., Marchioni E. Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg. J. Neurol. 2007, 254:1518-1523.
14. Saida T., Saida K., Dorfman S.H., Silberberg D.H., Sumner A.J., Manning M.C., Lisak R.P., Brown M.J. Experimental allergic neuritis induced by sensitization with galactocerebroside. Science 1979, 204:1103-1106.
15. Schwarz S., Mohr A., Knauth M., Wildemann B., Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 2001, 56:1313-1318.
16. Shahar E., Andraus J., Savitzki D., Pilar G., Zelnik N. Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins. J. Child Neurol. 2002, 17:810-814.
17. Tsukada N., Koh C.S., Yanagisawa N., Taketomi T., Behan P.O. Peripheral nervous tissue injury induced by galactocerebroside and galactocerebroside immune complexes. Acta Neuropathol. (Berl.) 1985, 66:274-282.
18. Yonezawa T., Hasegawa M., Arizona N., Okabe H. Antigenicity of galactocerebroside in experimental allergic demyelinating diseases. Acta Neuropathol. Suppl. (Berl.) 1981, 7:162-164.